Cite

HARVARD Citation

    van Waalwijk van Doorn, L. et al. (2016). Validation of soluble amyloid‐β precursor protein assays as diagnostic CSF biomarkers for neurodegenerative diseases. Journal of neurochemistry. 137 (1), pp. 112-121. [Online]. 
  
Back to record